Summary: Researchers have discovered why migraines are often one-sided, revealing that proteins released during aura are carried to pain-signaling nerves via cerebrospinal fluid. This study highlights...
WATCH TIME: 7 minutes “Tyrosine kinase inhibitors act like a ‘double-edged sword’, lowering inflammation while promoting autophagy, effectively clearing toxic proteins from the brain.” New therapies...
WATCH TIME: 4 minutes “It’s a really important pearl to remember: dedicate your time, give them your active listening, and that’s how you’re going to build...
WATCH TIME: 5 minutes “I think one of the biggest things I’ve learned in this study is that 100% of everyone has the patient’s care and...
WATCH TIME: 4 minutes Welcome to this special edition of Neurology News Network. I’m Marco Meglio. According to a recent announcement, REGENXBIO has initiated enrollment in...
Summary: A new study finds that higher inflammation in young adulthood is associated with reduced cognitive function in midlife. Researchers discovered that inflammation due to factors...
Summary: Researchers identified protein biomarkers in spinal fluid that can diagnose progressive supranuclear palsy (PSP) in living patients. Using high-throughput technology, they found a distinct protein...
Progressive supranuclear palsy (PSP), a mysterious and deadly neurological disorder, usually goes undiagnosed until after a patient dies and an autopsy is performed. But now, UC...
WATCH TIME: 5 minutes “We have a really great calling to educate other people about neurology, about neurologic conditions. And whether that’s the public or non-neurologists...
Stuart Isaacson, MD, FAAN Responder rate data from the open-label, phase 3 InfusON trial (NCT02339064) presented at the 3rd Annual Advanced Therapeutics in Movement and Related...
A pilot study conducted by Kessler Foundation researchers has shown promising results in the use of methylphenidate to enhance oculomotor function in individuals with multiple sclerosis...
WATCH TIME: 5 minutes “We haven’t had a new drug for almost 20 years because of failed trials, but now with these anti-amyloid antibodies, this is...